New approaches in cancer pharmacology: Drug design and development
Open Access
- 31 May 1992
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (6-7) , 1190-1200
- https://doi.org/10.1016/0959-8049(92)90483-i
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The cell membrane as a target for cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Signalling targets for anticancer drug developmentTrends in Pharmacological Sciences, 1991
- Gene therapy for cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Anticancer Drug DiscoveryJNCI Journal of the National Cancer Institute, 1991
- Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxinsJournal of Medicinal Chemistry, 1990
- In Defense of Cell-Line ScreeningJNCI Journal of the National Cancer Institute, 1990
- Screening Methods in Antineoplastic Drug DiscoveryJNCI Journal of the National Cancer Institute, 1990
- A genetic model for colorectal tumorigenesisCell, 1990
- 4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancerInternational Journal of Cancer, 1990
- Therapeutic Index: A Vital Component in Selection of Anticancer Agents for Clinical TrialJNCI Journal of the National Cancer Institute, 1989